Connect with us

Coronavirus

Russia To Begin Covid19 Vaccine Clinical Trials.

Published

on

Moscow, Russia. Photo| Courtesy

Russian scientists plan to start clinical trials within two weeks on a vaccine to combat the novel coronavirus, the country’s health minister was quoted as saying on Saturday.

Russia has the world’s third-highest toll of coronavirus infections after the United States and Brazil, and Kremlin officials have said the nation’s researchers are working on almost 50 different vaccine projects.

“The tests are under way and we plan to start clinical trials in the next two weeks,” Health Minister Mikhail Murashko was quoted as saying by the TASS news agency. He said volunteers had been selected to take part in the trials.

Drugmakers worldwide are rushing to develop treatments and vaccines for the virus that has caused 364,000 deaths globally. 

Advertisement

There are currently about 10 coronavirus vaccines being tested in humans and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development.

One of the Russian vaccine projects is being undertaken by the state-run Vektor Institute in Siberia, and the institute’s director general, Rinat Maksyutov, said on Saturday he hoped to complete clinical trials in mid-September.

Maksyutov said vaccine trials on animals had been successful.

Russia on Saturday reported 181 deaths from the coronavirus in the last 24 hours — down from the record 232 deaths registered the previous day, pushing up the nationwide death toll to 4,555.

Advertisement
Related Content:  China Approves Use Of Bear Bile To Treat Coronavirus Patients


Kenya Insights allows guest blogging, if you want to be published on Kenya’s most authoritative and accurate blog, have an expose, news TIPS, story angles, human interest stories, drop us an email on [email protected] or via Telegram

JohnBosco is a Liberated Mind. Polymath. Incisive Pundit on Governance, Independent Investigative Commentator and a Medic. For any insightful info email [[email protected]]

Advertisement
Advertisement
Advertisement

Facebook

Most Popular